If you think you have COVID-19 and are at high risk for severe infection, get tested and ask your doctor about monoclonal antibodies (mAbs) infusion treatment right away. Without the treatment, the infection can progress, which can result in lengthy ICU stays and possible placement on a ventilator. When given within 7 to 10 days after symptoms begin, monoclonal antibodies are up to 85 percent effective in reducing hospitalization due to COVID-19.
If you think you may be eligible for monoclonal antibodies treatment, contact your doctor or call for more information. You will be evaluated before treatment to make sure it is right for you.
How Do Monoclonal Antibodies (mAbs) Treat COVID-19?
Monoclonal antibodies are lab-created proteins that bind to the coronavirus that causes COVID-19 and prevent it from attaching to cells in the lungs. That action helps prevent pneumonia that often lands people in the hospital.
Monoclonal antibody infusion was approved by the FDA for emergency authorization use in November 2020. Researchers continue to evaluate it to understand more about which people gain the most benefit.
Who Is Eligible for Monoclonal Antibodies Infusion?
You may be eligible for monoclonal antibodies treatment if you test positive and you:
- are 65 years old or older
- have a chronic condition such as kidney disease, high blood pressure, diabetes, or respiratory disease
- are overweight or obese (BMI over 25)
- are immunocompromised
If You've Already Been Vaccinated, Pregnant, or Breastfeeding
If you’ve already been vaccinated and contract COVID-19, you may still benefit from this treatment. The treatment has also shown benefits in people who are pregnant or breastfeeding.
Treatment Takes an Hour or Less in Clinic
The one-time infusion is given through an IV and takes about an hour to administer in an outpatient clinic. Patients are monitored for about an hour, then go home.
Our infusion clinic is specially designed to safely care for people who are infected with COVID-19.